{"id":"NCT02094586","sponsor":"Bavarian Nordic","briefTitle":"A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults","officialTitle":"Phase 3 Randomized, Double-blind, Placebo-Controlled 3-Lot Study in Healthy Volunteers to Assess Immunogenicity, & Acceptability of a Single-dose of Live Oral Cholera Vaccine, Vibrio Cholerae O1 Serotype Inaba Vaccine Strain CVD 103-HgR","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05","primaryCompletion":"2015-02","completion":"2015-06","firstPosted":"2014-03-24","resultsPosted":"2021-07-15","lastUpdate":"2023-06-28"},"enrollment":3146,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Cholera"],"interventions":[{"type":"BIOLOGICAL","name":"PXVX0200 Lot A","otherNames":[]},{"type":"BIOLOGICAL","name":"PXVX0200 Lot B","otherNames":[]},{"type":"BIOLOGICAL","name":"PXVX0200 Lot C","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"PXVX0200 Lot A","type":"EXPERIMENTAL"},{"label":"PXVX0200 Lot B","type":"EXPERIMENTAL"},{"label":"PXVX0200 Lot C","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary goal of this Phase III study is to compare 3 lots for consistency of manufacture.","primaryOutcome":{"measure":"Geometric Mean Ratio (GMR) at Day 11 for Vaccine Lots A and B","timeFrame":"Day 11","effectByArm":[{"arm":"PXVX0200 Lot A","deltaMin":9220,"sd":null},{"arm":"PXVX0200 Lot B","deltaMin":10034,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":13},"locations":{"siteCount":25,"countries":["United States","Australia"]},"refs":{"pmids":["29317118"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":926},"commonTop":["Headache","Fatigue","Upper Respiratory Tract Infection","Back Pain","Flatulence"]}}